Details of the Drug
General Information of Drug (ID: DMJFY9Z)
Drug Name |
4-Bromo-N-(4-phenyl-thiazol-2-yl)-benzamide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL61836; 4-Bromo-N-(4-phenyl-thiazol-2-yl)-benzamide; 4-bromo-N-(4-phenyl-1,3-thiazol-2-yl)benzamide; AC1LKC2E; Oprea1_799831; SCHEMBL17107249; MolPort-001-934-338; ZINC5775827; BDBM50101783; AKOS000591432; MCULE-9538176345; BAS 00470402; N-(4-Phenyl-2-thiazolyl)-4-bromobenzamide; ST50002847
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 359.2 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 4.5 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||